INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 280 filers reported holding INSMED INC in Q4 2023. The put-call ratio across all filers is 7.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $21,594 | +1341.5% | 322,299 | +483.8% | 0.03% | +1300.0% |
| Q1 2024 | $1,498 | -13.9% | 55,209 | -1.6% | 0.00% | 0.0% |
| Q4 2023 | $1,739 | +31.7% | 56,131 | +7.3% | 0.00% | 0.0% |
| Q3 2023 | $1,320 | +22.8% | 52,290 | +2.6% | 0.00% | +100.0% |
| Q2 2023 | $1,075 | -11.2% | 50,948 | -28.3% | 0.00% | -50.0% |
| Q1 2023 | $1,211 | -34.7% | 71,052 | -23.5% | 0.00% | -33.3% |
| Q4 2022 | $1,855 | -99.9% | 92,834 | +8.2% | 0.00% | 0.0% |
| Q3 2022 | $1,849,000 | +15.5% | 85,834 | +5.7% | 0.00% | +50.0% |
| Q2 2022 | $1,601,000 | -39.7% | 81,180 | -28.1% | 0.00% | -33.3% |
| Q1 2022 | $2,655,000 | -7.7% | 112,959 | +7.0% | 0.00% | 0.0% |
| Q4 2021 | $2,876,000 | +5.9% | 105,566 | +7.0% | 0.00% | 0.0% |
| Q3 2021 | $2,717,000 | -16.7% | 98,641 | -13.9% | 0.00% | 0.0% |
| Q2 2021 | $3,260,000 | -21.3% | 114,540 | -5.8% | 0.00% | -40.0% |
| Q1 2021 | $4,143,000 | +1.0% | 121,650 | -1.2% | 0.01% | 0.0% |
| Q4 2020 | $4,100,000 | +3.1% | 123,150 | -0.5% | 0.01% | 0.0% |
| Q3 2020 | $3,977,000 | +16.7% | 123,750 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $3,408,000 | +91.6% | 123,750 | +11.5% | 0.00% | +33.3% |
| Q1 2020 | $1,779,000 | -39.8% | 110,950 | -10.3% | 0.00% | -25.0% |
| Q4 2019 | $2,954,000 | +33.1% | 123,700 | -1.7% | 0.00% | +33.3% |
| Q3 2019 | $2,220,000 | -15.2% | 125,850 | +23.0% | 0.00% | 0.0% |
| Q2 2019 | $2,619,000 | -10.6% | 102,302 | +1.5% | 0.00% | -25.0% |
| Q1 2019 | $2,930,000 | +197.5% | 100,782 | +34.2% | 0.00% | +300.0% |
| Q4 2018 | $985,000 | -43.3% | 75,100 | -12.6% | 0.00% | -50.0% |
| Q3 2018 | $1,737,000 | -14.5% | 85,900 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $2,032,000 | +9.9% | 85,900 | +4.6% | 0.00% | +50.0% |
| Q1 2018 | $1,849,000 | -24.7% | 82,100 | +4.2% | 0.00% | -33.3% |
| Q4 2017 | $2,457,000 | +17.3% | 78,800 | +17.4% | 0.00% | 0.0% |
| Q3 2017 | $2,094,000 | +50.5% | 67,100 | -17.2% | 0.00% | +50.0% |
| Q2 2017 | $1,391,000 | +18.4% | 81,044 | +20.8% | 0.00% | 0.0% |
| Q1 2017 | $1,175,000 | +32.3% | 67,101 | +0.0% | 0.00% | +100.0% |
| Q4 2016 | $888,000 | -8.8% | 67,100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $974,000 | +64.0% | 67,100 | +11.5% | 0.00% | 0.0% |
| Q2 2016 | $594,000 | -22.1% | 60,200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $763,000 | -30.2% | 60,200 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $1,093,000 | -2.2% | 60,200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,118,000 | -31.4% | 60,200 | -9.8% | 0.00% | 0.0% |
| Q2 2015 | $1,629,000 | +2527.4% | 66,728 | +2124.3% | 0.00% | – |
| Q1 2015 | $62,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 955,462 | $24,460,000 | 13.75% |
| Foresite Capital Management IV, LLC | 1,561,185 | $39,966,000 | 11.30% |
| Asymmetry Capital Management, L.P. | 730,440 | $18,699,000 | 10.13% |
| NEXTHERA CAPITAL LP | 470,741 | $12,051,000 | 10.04% |
| Palo Alto Investors LP | 7,890,917 | $202,007,000 | 9.82% |
| Vivo Capital, LLC | 1,748,174 | $44,753,000 | 4.19% |
| ACUTA CAPITAL PARTNERS, LLC | 435,500 | $11,149,000 | 3.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $9,111,000 | 3.38% |
| Consonance Capital Management LP | 1,711,150 | $43,805,000 | 3.10% |
| Opus Point Partners Management, LLC | 26,936 | $690,000 | 1.02% |